A recent conversation with a US biopharma senior director highlighted a critical talent gap: a strong demand for individuals with strategic management, critical thinking, and advanced business acumen-skills beyond traditional operational excellence. After the conversation, I rushed home and picked…
Long-Term Safety of PCSK9 Inhibitors Remains to Be Determined: New Atherosclerosis Prevention Guidelines
To read the full story
ACADEMIA
- Japan Hypertension Society to Release Revised Treatment Guidelines in August
July 28, 2025
- Dust Mite Sublingual Immunotherapy Linked to Lower Antibiotic Use in Children
July 25, 2025
- Japan Embraces New AML Era with Tibsovo Debut, Says Hematologist
June 30, 2025
- Keytruda Label Update Unlocks First New Treatment in 14 Years for HER2-Positive Gastric Cancer: Oncologist
June 24, 2025
- Oncologist Hails Amgen’s Imdelltra as “First New Option in 20 Years” for SCLC
June 23, 2025
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…